Drug Trial Radar · NCT03357822
A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B
Last checked: Nov 20, 2026Latest source record: Apr 25, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,000
Planned (sponsor's estimate)
Start
Jan 25, 2018
Primary completion
Jan 25, 2022
Study completion Jul 25, 2022
Sponsor
- Lead sponsor
- Tongji HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 30, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the prospective real-world study is to evaluate whether sequential combination therapy with pegylated interferon plus entecavir/tenofovir could induce higher rates of HBsAg loss in nucleoside-treated patients with chronic hepatitis B compared to continuous nucleoside treatment.
Conditions
- Chronic Hepatitis B
Interventions
Pegylated interferonDrug
180ug Pegylated interferon is injected subcutaneously once a week
EntecavirDrug
0.5mg entecavir is orally taken every day
Tenofovir disoproxil fumarateDrug
300mg tenofovir is orally taken every day
Primary outcomes
What the sponsor says the trial is designed to measure.
- HBsAg loss rateTime frame: at week 48
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
302 Military Hospital of China
Beijing, Beijing Municipality, China · Recruiting
BeiJing YouAn Hospital, Capital Medical University
Beijing, Beijing Municipality, China · Not yet recruiting
The First Hospital Affiliated to AMU
Chongqing, Chongqing Municipality, China · Not yet recruiting
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China · Not yet recruiting
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China · Not yet recruiting
The First Affiliated Hospital of College of Medicine, Zhejiang University
Zhejiang, Hangzhou, China · Not yet recruiting
Departmen of infectious disease, Xiangya Hospital, Central-south Universit
Changsha, Hunan, China · Not yet recruiting
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China · Not yet recruiting
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China · Not yet recruiting
The Second Hospital of Nanjing
Nanjing, Jiangsu, China · Not yet recruiting
Traditional Chinese Medicine,Xiamen Hospital
Shantou, Xiamen, China · Not yet recruiting
The first affiliated hospital of Wenzhou medical universtiy
Wenzhou, Zhejiang, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.